149 related articles for article (PubMed ID: 15467426)
1. Perspectives of SEREX-defined antigens in diagnosis and immunotherapy for gastric cancer.
Wang Y; Gu Q; Liu B; Zhu Z
Cancer Biol Ther; 2004 Sep; 3(9):806-11. PubMed ID: 15467426
[TBL] [Abstract][Full Text] [Related]
2. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
3. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
Jäger D
Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
[TBL] [Abstract][Full Text] [Related]
5. Mapping the high throughput SEREX technology screening for novel tumor antigens.
Zhou S; Yi T; Zhang B; Huang F; Huang H; Tang J; Zhao X
Comb Chem High Throughput Screen; 2012 Mar; 15(3):202-15. PubMed ID: 22221053
[TBL] [Abstract][Full Text] [Related]
6. Identification of human tumor antigens by serological analysis of recombinant cDNA expression libraries (SEREX).
Scanlan MJ
Curr Protoc Immunol; 2005 Mar; Chapter 20():Unit 20.7. PubMed ID: 18432945
[TBL] [Abstract][Full Text] [Related]
7. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning.
Jäger D; Taverna C; Zippelius A; Knuth A
Cancer Immunol Immunother; 2004 Mar; 53(3):144-7. PubMed ID: 14727084
[TBL] [Abstract][Full Text] [Related]
8. Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX.
Song MH; Ha JC; Lee SM; Park YM; Lee SY
Biochem Biophys Res Commun; 2011 May; 408(2):195-201. PubMed ID: 21338577
[TBL] [Abstract][Full Text] [Related]
9. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.
Stanton SE; Gad E; Corulli LR; Lu H; Disis ML
Vaccine; 2019 Jun; 37(27):3552-3561. PubMed ID: 31126858
[TBL] [Abstract][Full Text] [Related]
12. Identification of tumour antigens by serological analysis of cDNA expression cloning.
Li G; Miles A; Line A; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
[TBL] [Abstract][Full Text] [Related]
13. Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer.
Lee SY; Williamson B; Caballero OL; Chen YT; Scanlan MJ; Ritter G; Jongeneel CV; Simpson AJ; Old LJ
Cancer Immun; 2004 Nov; 4():13. PubMed ID: 15546177
[TBL] [Abstract][Full Text] [Related]
14. Tumor associated antigen recognition by autologous serum in patients with breast cancer.
Qian F; Odunsi K; Blatt LM; Scanlan MJ; Mannan M; Shah N; Montgomery J; Haddad F; Taylor M
Int J Mol Med; 2005 Jan; 15(1):137-44. PubMed ID: 15583840
[TBL] [Abstract][Full Text] [Related]
15. Serological identification of antigens associated with renal cell carcinoma.
Koroleva EP; Lagarkova MA; Mesheryakov AA; Scanlan MJ; Old LJ; Nedospasov SA; Kuprash DV
Russ J Immunol; 2002 Oct; 7(3):229-38. PubMed ID: 12674932
[TBL] [Abstract][Full Text] [Related]
16. Serological analysis of expression cDNA libraries (SEREX): an immunoscreening technique for identifying immunogenic tumor antigens.
Chen YT; Gure AO; Scanlan MJ
Methods Mol Med; 2005; 103():207-16. PubMed ID: 15542909
[TBL] [Abstract][Full Text] [Related]
17. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer antigens recognized by the humoral immune system.
Monji M; Senju S; Nakatsura T; Yamada K; Sawatsubashi M; Inokuchi A; Nishimura Y
Biochem Biophys Res Commun; 2002 Jun; 294(3):734-41. PubMed ID: 12056832
[TBL] [Abstract][Full Text] [Related]
19. Serological identification of immunogenic antigens in acute monocytic leukemia.
Chen G; Zhang W; Cao X; Li F; Liu X; Yao L
Leuk Res; 2005 May; 29(5):503-9. PubMed ID: 15755502
[TBL] [Abstract][Full Text] [Related]
20. Serological identification and bioinformatics analysis of immunogenic antigens in osteosarcoma.
Liao B; Ma B; Liu Z; Zhang H; Long H; Yang T; Fan Q
Cancer Biol Ther; 2007 Nov; 6(11):1805-9. PubMed ID: 18032929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]